comparemela.com

Latest Breaking News On - ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு - Page 2 : comparemela.com

Pulsify Medical closes second round Series A funding of EUR 5 4 million for wearable ultrasound heart monitor patch

Search jobs 04-May-2021 Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced the second closing of the Series A funding round with EUR 3.75 million in equity and EUR1.65 million as a non-dilutive grant.  Leuven, Belgium, 4 May 2021 - Pulsify Medical is a digital medical technology company developing wearable ultrasound patches which will monitor vital organs in real-time. The new and disruptive technology will address a serious unmet need for continuous cardiac monitoring in ICUs, hospitals, and homes across the world. 

Rejuvenate Biomed Secures EUR 3 2 Million Series A Round to Advance Development of Healthy Aging Products

Search jobs 02-Mar-2021 Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces it has completed a EUR 3.2 million Series A round. The funding is being used to advance the development of Rejuvenate’s lead candidate RJx-01 in both acute and chronic sarcopenia (disuse-induced and age-related muscle failure). The financing included lead investor Vesalius Biocapital III and private non-disclosed investors, as well as existing investors. Additionally, Rejuvenate gratefully acknowledges the ongoing support of Flanders Innovation and Entrepreneurship (VLAIO) in non-dilutive funding. Concurrent with the closing, the co

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.